The Inaugural Paris International Liver Meeting (PILM 2026)
The first Paris International Liver Meeting (PILM 2026) was organized by Professors Laurent Castera and Zobair Younossi, together with the Scientific Committee. This three-day meeting was attended by 722 participants (449 on site and 273 virtual) from 67 countries and was highly successful. Scientific sessions covered key areas including MASLD, MetALD, alcohol-associated liver disease, hepatocellular...Continue reading→
Inaugural Paris International Liver Meeting 2026: Bringing Cutting-Edge Science and Clinical Practice Together in Liver Disease
We’re excited to take part in the inaugural Paris International Liver Meeting (PILM), held 19–21 January 2026 at the historic Maison de la Chimie in Paris. PILM 2026 will showcase a robust program featuring global leaders in Steatotic Liver Disease (MASLD/MASH, MetALD, ALD), cholestatic liver disease (PBC, PSC), viral hepatitis, and complications of cirrhosis. Each...Continue reading→
Major Publications in Hepatology from the Global NASH/MASH Council (GNC)
Members of the Global NASH/MASH Council (GNC) have recently published two major original manuscripts in Hepatology. The GNC Collaborators created the Global-MASLD project, a cohort of 17,792 biopsy-proven MASLD cases with extensive clinical, laboratory, non-invasive test (NIT) data, and long-term outcomes. In the first manuscript, “Global Performance of Non-Invasive Tests in MASLD: Insights from the...Continue reading→
The Global NASH/MASH Council (GNC) and Global Liver Council (GLC) Actively Participated in the AASLD Meeting in Washington, D.C. (November 7–11)
This year’s AASLD meeting was a highly productive and engaging event for members of the Global NASH/MASH Council (GNC) and Global Liver Council (GLC). In addition to hosting a successful joint annual GNC/GLC meeting featuring insightful presentations and discussions, members also delivered a total of 18 research presentations, including 4 oral presentations and 14 poster...Continue reading→
Global NASH/MASH Council (GNC) and Global Liver Council (GLC) Bi-annual Meeting at AASLD 2025, Washington, D.C.
Over 100 members of the Global NASH/MASH Council (GNC) and the Global Liver Council (GLC), representing leading hepatology experts from more than 30 countries worldwide, attended the 11th bi-annual GNC/GLC meeting held during AASLD 2025 in Washington, D.C. The meeting commenced with opening remarks from Professor Zobair Younossi, Chair of the GNC/GLC, who highlighted the...Continue reading→
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
MASH is rapidly emerging as one of the most common causes of chronic liver disease worldwide, yet its economic impact has often been underestimated. The Global NASH/MASH Council (GNC) recently conducted an in-depth analysis of the future burden of MASH across nine countries, including the U.S., Germany, France, UK, Italy, Spain, Japan, Brazil, and Saudi...Continue reading→
International Paris Liver Meeting 2026- Save the Date
Dear Colleagues, We would like to invite you to save the date for the International Paris Liver Meeting 2026, a three-day program taking place January 19–21, 2026, covering the latest topics in hepatology, including steatotic liver disease (MASLD, MetALD, ALD), cholestatic liver diseases, viral hepatitis, hepatocellular carcinoma (HCC), and complications of cirrhosis. Join the international...Continue reading→
The Global NASH/MASH Council Meeting at ALEH 2025
The Global NASH/MASH Council (GNC) held a highly successful meeting during the annual ALEH Congress in Lima, Peru. Experts from across Latin America discussed key topics related to MASLD in the region, along with potential collaborative projects with GNC. The session was highly interactive and productive. GNC looks forward to strengthening its partnership with ALEH...Continue reading→
Global Consensus Recommendations for Metabolic Dysfunction Associated Steatotic Liver Disease and Steatohepatitis
This month’s cover of the prestigious journal Gastroenterology features a landmark study by the Global NASH/MASH Council (GNC), which developed global consensus recommendations on the burden, risk stratification, and treatment of MASLD/MASH. By systematically reviewing 61 guidance documents worldwide, the study identified 46 areas of discordance that may create uncertainty for clinicians. Through a four-round...Continue reading→
Managing MASLD Through Preventive Hepatology: Integrating Policy Reform, Public Health, and Personalized Care
The prevalence of MASLD/MASH is rising globally, highlighting the urgent need for public health policies that emphasize both prevention and personalized care. MASLD/MASH carries significant clinical, humanistic, and economic burdens worldwide. Primary prevention strategies should prioritize lifestyle interventions guided by a social nutrition agenda, alongside public health initiatives to increase awareness among healthcare practitioners and...Continue reading→